The Calmer Co International Ltd (ASX: CCO) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
The Calmer Co International Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
The Calmer Co International Ltd (ASX: CCO)
Latest News
Share Market News
The Fiji Kava (ASX:FIJ) share price rocketed 26% this morning. Here's why
Share Market News
Fiji Kava share price explodes 71% after company lands partnership to supply to China
Share Market News
Fiji Kava share price soars 90% on Blackmores subsidiary agreement, trade paused
CCO ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About The Calmer Co International Ltd
The Calmer Co International Ltd is mainly engaged in the research, development, and selling of kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and viaits Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its reportable segments are; Fiji Kava Australia Trading Pty Ltd (Fiji Kava Australia Trading) which derives maximum revenue, South Pacific Elixirs Pty Limited (SPE Fiji), Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA). Geographically, it derives key revenue from Australia andthe rest from Fiji, and other regions.
CCO Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
30 Sep 2024 | $0.01 | $0.00 | 0.00% | 866,017 | $0.01 | $0.01 | $0.01 |
27 Sep 2024 | $0.01 | $0.00 | 0.00% | 9,296,588 | $0.01 | $0.01 | $0.01 |
26 Sep 2024 | $0.01 | $0.00 | 0.00% | 6,285,153 | $0.01 | $0.01 | $0.01 |
25 Sep 2024 | $0.01 | $0.00 | 0.00% | 4,246,001 | $0.01 | $0.01 | $0.01 |
24 Sep 2024 | $0.01 | $0.00 | 0.00% | 3,220,625 | $0.01 | $0.01 | $0.01 |
23 Sep 2024 | $0.01 | $0.00 | 0.00% | 2,705,503 | $0.01 | $0.01 | $0.01 |
20 Sep 2024 | $0.01 | $0.00 | 0.00% | 2,087,022 | $0.01 | $0.01 | $0.01 |
19 Sep 2024 | $0.01 | $0.00 | 0.00% | 16,503,012 | $0.01 | $0.01 | $0.01 |
18 Sep 2024 | $0.01 | $0.00 | 0.00% | 1,803,167 | $0.01 | $0.01 | $0.01 |
17 Sep 2024 | $0.01 | $0.00 | 0.00% | 6,006,612 | $0.01 | $0.01 | $0.01 |
16 Sep 2024 | $0.01 | $0.00 | 0.00% | 11,599,213 | $0.01 | $0.01 | $0.01 |
13 Sep 2024 | $0.01 | $0.00 | 0.00% | 12,569,156 | $0.01 | $0.01 | $0.01 |
12 Sep 2024 | $0.01 | $0.00 | 0.00% | 20,083,959 | $0.01 | $0.01 | $0.01 |
11 Sep 2024 | $0.01 | $0.00 | 0.00% | 18,539,708 | $0.01 | $0.01 | $0.01 |
10 Sep 2024 | $0.01 | $0.00 | 0.00% | 4,105,717 | $0.01 | $0.01 | $0.01 |
09 Sep 2024 | $0.01 | $0.00 | 0.00% | 3,713,879 | $0.01 | $0.01 | $0.01 |
06 Sep 2024 | $0.01 | $0.00 | 0.00% | 4,835,031 | $0.01 | $0.01 | $0.01 |
05 Sep 2024 | $0.01 | $0.00 | 0.00% | 1,517,070 | $0.01 | $0.01 | $0.01 |
04 Sep 2024 | $0.01 | $0.00 | 0.00% | 7,411,887 | $0.01 | $0.01 | $0.01 |
03 Sep 2024 | $0.01 | $0.00 | 0.00% | 2,280,454 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
03 Sep 2024 | Zane Yoshida | Issued | 20,000,000 | $160,000 |
Issued under employee share plan.
|
03 Sep 2024 | Anthony Noble | Sell | 7,350,000 | $58,800 |
As advised by the company.
|
03 Sep 2024 | Anthony Noble | Issued | 15,000,000 | $120,000 |
Issued under employee share plan.
|
02 Jul 2024 | Anthony Noble | Issued | 666,749 | $2,666 |
Rights issue.
|
02 Jul 2024 | Anthony Noble | Issued | 333,375 | $2,667 |
Rights issue.
|
02 Jul 2024 | Griffon Emose | Issued | 1,925,925 | $7,703 |
Rights issue.
|
02 Jul 2024 | Griffon Emose | Issued | 962,962 | $7,703 |
Rights issue.
|
02 Jul 2024 | James Dack | Issued | 5,000,000 | $40,000 |
Rights issue.
|
02 Jul 2024 | James Dack | Issued | 10,000,000 | $40,000 |
Rights issue.
|
02 Jul 2024 | Zane Yoshida | Issued | 584,701 | $4,677 |
Rights issue.
|
02 Jul 2024 | Zane Yoshida | Issued | 1,169,403 | $4,677 |
Rights issue.
|
19 Mar 2024 | Anthony Noble | Sell | 5,111,111 | $22,999 |
Off-market trade.
|
19 Mar 2024 | Anthony Noble | Sell | 744,608 | $3,350 |
Off-market trade.
|
05 Dec 2023 | Anthony Noble | Issued | 5,111,111 | $20,444 |
Director remuneration.
|
05 Dec 2023 | Anthony Noble | Issued | 5,111,111 | $20,444 |
Director remuneration.
|
05 Dec 2023 | James Tonkin | Issued | 4,111,111 | $16,444 |
Director remuneration.
|
05 Dec 2023 | Griffon Emose | Issued | 4,111,111 | $16,444 |
Director remuneration.
|
05 Dec 2023 | Zane Yoshida | Issued | 5,111,111 | $20,444 |
Director remuneration.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Zane Yoshida | Non-Executive Director | Dec 2018 |
Mr Yoshida was born and raised in the Fiji Islands. Professionally, he has been involved in various of start-ups in Australia, Asia and the United States. He is the Founder and Executive Director of The Calmer Co, producing a range of farm to shelf kava supplements and complementary medicines that are manufactured to HACCP/GMP standards and launched in various international markets under the FijiKava and TakiMai brand. These countries include Australia, New Zealand, USA and Fiji. He is a member of the Australian Institute of Company Directors and Vice President of the Australia Fiji Business Council.
|
Mr James Dack | Non-Executive DirectorNon-Executive Chairman | Sep 2022 |
Mr Dack began his career at St Vincent's Hospital, as a porter and after five years of hard work he was promoted to the position of payroll manager responsible for 2500 staff. He was approached by the Industrial relations division of the Department of Health to run the whole New South Wales public hospital payroll system. When James left the Department of Health, he became a founding partner of one of the most successful real estate companies in Australia. In 2014 he started Sunshine Group Investments where he is currently the Managing Director. He is on the Board of the Police and Citizens Youth Clubs New South Wales. James was awarded the Order of Australia Medal in the Kings Birthday honours for services to youth.
|
Dr Anthony Noble | Chief Executive OfficerManaging Director | May 2021 |
Dr Noble joined FijiKava. Prior to this he was CEO of Australian Biotherapeutics, a manufacturer of live biotherapeutics based in Coolum Beach, Queensland. Anthony worked at SFI Health and held roles as Managing Director of SFI Research Pty Ltd, as Global Head of Innovation, Group Head of North Asia and as General Manager of the SFI-Shineway Chinese Joint Venture. Anthony was Principal Scientist, for Cryosite Ltd and a lead inspector for the Human Tissue Authority (UK).
|
Mr James S Tonkin | Non-Executive Director | Jan 2023 |
Mr Tonkin is a retired Private Branding Agency owner. He has built and developed in market, many food and beverage brands mostly in the US marketplace. He was a entrepreneur as well as building and selling numerous businesses in his early career. Bringing more than 40 years in consulting and brand building experience in a range of household names globally gives James the ability to understand the strategies and marketability of products and service. James Tonkin has served on over 100 Boards in his long career.
|
Mr Griffon Emose | Non-Executive Director | Jan 2023 |
Mr Emose is the Managing Director of Kontiki Capital, a Fiji-based investment banking firm. He has experience in corporate finance and investment advisory, working in Fiji and the Pacific Islands. Prior to joining the Board, he was involved with CCO in an advisory capacity, overseeing the investment of Fiji institutional capital into CCO.
|
Ms Natalie Sylvia Climo | Company Secretary | Jan 2024 |
-
|
Zane Yoshida | Chief Operating Officer |
-
|
|
Natalie Sylvia Climo | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Ace Property Holdings | 38,000,000 | 4.31% |
James Dack | 30,000,000 | 3.40% |
Mr Langley & Tarabay | 29,166,667 | 3.31% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> | 27,456,310 | 3.11% |
Wayne Elsom | 26,398,582 | 2.99% |
Ryan Gorman, Family & Gormco | 22,651,319 | 2.57% |
Citicorp Nominees Pty Limited | 20,453,998 | 2.32% |
Ian Leete, Family & Mial Enterprises | 19,238,346 | 2.18% |
Bradfield Partners - Robert, Nicholas, Matt, Andrew & Ben Schulz | 18,935,125 | 2.15% |
Zane Yoshida | 17,902,933 | 2.03% |
Mr Fangtao Meng | 15,679,008 | 1.78% |
Netwealth Investments Limited <Wrap Services A/C> | 14,443,534 | 1.64% |
Netwealth Investments Limited<Super Services A/C> | 13,816,776 | 1.57% |
Matthew Reede | 10,494,444 | 1.19% |
Toffolo Nyc Pty Ltd<Toffolo Nyc S/F A/C> | 10,000,000 | 1.13% |
Mr Tong Siong Tan | 9,442,709 | 1.07% |
Sarantzouklis Family - Sarantzouklis Investments | 9,375,000 | 1.06% |
Mr Stacey Hubert Carter | 8,976,671 | 1.02% |
Cscde Pty Ltd <Bounds Green Super Fund A/C> | 8,350,000 | 0.95% |
Bds Investments (Nsw) Pty Ltd <Bds S/F A/C> | 8,000,000 | 0.91% |
Benchmark Fine Foods Pty Limited <Benchmark Super Fund A/C> | 8,000,000 | 0.91% |
Edengreen Pty Ltd <The Ede Super Fund A/C> | 8,000,000 | 0.91% |
Enster Pty Ltd <Rp Drummond Pl S/F A/C> | 8,000,000 | 0.91% |
Pharmaceutical Sundries Pty Ltd <The Bennett Family S/F A/C> | 8,000,000 | 0.91% |
Pj & Tk Watherston Pty Ltd <Petess Wathers S/F A/C> | 8,000,000 | 0.91% |
Rarebit Pty Limited <Rarebit Super Fund A/C> | 8,000,000 | 0.91% |
Vin Singh Pty Ltd <Dhanni Super Fund A/C> | 8,000,000 | 0.91% |